Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscap… (NCT07216534) | Clinical Trial Compass
RecruitingNot Applicable
Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants
United States32 participantsStarted 2026-09-01
Plain-language summary
This clinical trial compares virtual reality viewing of an unaltered streetscape versus a digitally manipulated opposite streetscape to assess the psychosocial response in participants. Visible measures of neighborhood factors might be associated with health outcomes and risk factors of those outcomes. Short-term exposure to virtual reality environments representing very high or very low levels of neighborhood physical disorder - presence or absence of garbage/litter, presence or absence of graffiti, presence or absence of an abandoned building, presence or absence of large dumpsters, poor or very well-kept building conditions, poor or very well-kept yard conditions, poor or very well-kept road verge conditions may be a safe and effective way to assess psychosocial response in participants.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults 18+
* Must currently live (4+ night/week) at the residence being studied. Only one resident per household will be selected
* Must understand and be able to read English
* Must agree to have residence photographed
* Must be able to wear a VR head mounted display
* Must live in neighborhood that has been selected for study
* Must be willing and able to attend an approximately 2 hour in-person visit on Ohio State University (OSU) campus
Exclusion Criteria:
* Pregnant women
* Visual or mobility impairment
* Cannot have epilepsy or other condition that would inhibit them from being able to use a VR headset
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in heart rate variability
Timeframe: From baseline to completion of virtual reality (VR) viewings, up to 1 day
2
Change in skin conductance
Timeframe: From baseline to completion of VR viewings, up to 1 day
3
Affective reaction
Timeframe: After completion of VR viewings, up to 1 day
4
Anxiety
Timeframe: After completion of VR viewings, up to 1 day
5
Participant reported discomfort
Timeframe: After completion of VR viewings, up to 1 day
Trial details
NCT IDNCT07216534
SponsorOhio State University Comprehensive Cancer Center
Sponsor typeOTHER
Study typeINTERVENTIONAL
Primary completion2026-12-31
Contact for this trial
The Ohio State University Comprehensive Cancer Center